thiamine pyrophosphate has been researched along with Helicobacter Infections in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bassaganya-Riera, J; Bruce, AM; Burgess, SL; Guerrant, RL; Hoffman, PS; Hontecillas, R; Macdonald, TL; Olekhnovich, I; Viladomiu, M; Warren, CA | 1 |
1 other study(ies) available for thiamine pyrophosphate and Helicobacter Infections
Article | Year |
---|---|
Preclinical studies of amixicile, a systemic therapeutic developed for treatment of Clostridium difficile infections that also shows efficacy against Helicobacter pylori.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Benzamides; Biological Availability; Cell Line; Cell Survival; Dogs; Drug Evaluation, Preclinical; Half-Life; Helicobacter Infections; Helicobacter pylori; Hepatocytes; Humans; Male; Microbial Sensitivity Tests; Microbiota; Microsomes, Liver; Pyruvate Synthase; Rats; Thiamine Pyrophosphate; Thiazoles | 2014 |